title: Feasibility of short-term infusion of magnesium sulfate in pediatric patients with status asthmaticus.
abstract: OBJECTIVE
  This report describes the feasibility of high-dose magnesium sulfate infusion in pediatric patients with status asthmaticus.
  
  
  METHODS
  Retrospective chart review over a 3-year period of all patients younger than 18 years of age with status asthmaticus who underwent a high-dose magnesium sulfate infusion for 4 hours. All patients were breathing spontaneously but were refractory to conventional therapy. The magnesium sulfate infusion regimen was 50 mg/kg (for patients weighing >30 kg) or 75 mg/kg (for those weighing ≤30 kg) over a period of 30 to 45 minutes, followed by a continuous infusion of 40 mg/kg/hr for 4 hours. Information regarding vital and clinical respiratory signs, serum magnesium (SrMg), ionized magnesium (iMg), electrocardiograms, and cardiac troponin levels were retrieved. We analyzed the relationship between SrMg and iMg by using linear regression analysis.
  
  
  RESULTS
  Nineteen patients were included. At the end of the infusion, SrMg levels were 4.4 ± 0.8 mg/dL, and iMg levels were 0.95 ± 0.2 mmol/L. SrMg levels only moderately predicted iMg (r(2) = 0.541). There were no reports of hypotension, respiratory failure, neurological problems, or nausea. Discomfort at the site of infusion was reported in three cases. Troponin levels (n = 12) and electrocardiograms (n = 12), when available, were noted at the end of the infusion and were normal in all patients p=0.01.
  
  
  CONCLUSIONS
  In this case series, short-term high-dose administration of magnesium sulfate in the context of status asthmaticus was feasible, and we did not observe clinical complications with its use. Total SrMg was inadequate to reflect the active form of magnesium, iMg. The dose used achieved theoretical therapeutic levels of iMg.
authors.affiliation: Wolfson Children's Hospital/Baptist Health, Jacksonville, Florida  ; University of Florida College of Medicine, Jacksonville, Florida.
authors.forename: Jose
authors.initials: J
authors.lastname: Irazuzta
authors.forename: Tosha
authors.initials: T
authors.lastname: Egelund
authors.forename: Sarah K
authors.initials: SK
authors.lastname: Wassil
authors.forename: Christian
authors.initials: C
authors.lastname: Hampp
keywords: asthma; feasibility; infusion; magnesium sulfate; status asthmaticus